+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Years +
All Genders
ID07227831

Evaluating the TheraBionic P1 Device in Women with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer After Endocrine Therapy

Led by Barbara Ann Karmanos Cancer Institute · Updated on 2026-08-26

82

Participants Needed

8

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of the TheraBionic P1 device in patients with advanced or metastatic hormone receptor positive, HER2 negative breast cancer who have progressed on standard treatment options. The study aims to determine if this device affects progression-free survival and overall survival, while also assessing its long-term safety, tolerability, and how the disease responds to the treatment. Participants will self-administer the TheraBionic P1 device, which delivers amplitude-modulated electromagnetic fields in three 60-minute sessions dailymorning, midday, and evening. The treatment period can last up to 12 months, during which participants use the device continuously. This is a single-group study focusing on the effects of this device without comparison to other treatments or placebos. During the study, participants will be regularly monitored for progression-free survival from the start of treatment up to five years after discontinuation or death. Researchers will also evaluate overall survival, response rates, disease control, duration of response, time to progression, and device tolerability. Monitoring includes adherence to treatment schedules and safety assessments. The total participation can last up to five years, covering treatment and follow-up periods.

CONDITIONS

Brief Title

A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer

Research Team

H

Hadeel Assad, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here